NCT00518401View on ClinicalTrials.gov

Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2009

Conditions
Critical Limb IschemiaPeripheral Vascular Disease
Interventions
BIOLOGICAL

Mesendo

Intramuscular injection of 0.5 cc per site of the combination stem cell mixture in approximately 40 different ischemic sites of the gastrocnemius area of the calf.

Trial Locations (1)

70433

TCA Cellular Therapy, Covington

Sponsors
All Listed Sponsors
lead

TCA Cellular Therapy

INDUSTRY